Dianthus Therapeutics (DNTH) Gross Profit: 2022-2025
Historic Gross Profit for Dianthus Therapeutics (DNTH) over the last 3 years, with Sep 2025 value amounting to $396,000.
- Dianthus Therapeutics' Gross Profit fell 81.77% to $396,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $3.1 million, marking a year-over-year decrease of 42.31%. This contributed to the annual value of $6.2 million for FY2024, which is 120.63% up from last year.
- As of Q3 2025, Dianthus Therapeutics' Gross Profit stood at $396,000, which was up 105.18% from $193,000 recorded in Q2 2025.
- In the past 5 years, Dianthus Therapeutics' Gross Profit ranged from a high of $2.2 million in Q3 2024 and a low of $193,000 during Q2 2025.
- In the last 3 years, Dianthus Therapeutics' Gross Profit had a median value of $924,000 in 2023 and averaged $985,182.
- Its Gross Profit has fluctuated over the past 5 years, first skyrocketed by 211.27% in 2024, then slumped by 89.64% in 2025.
- Quarterly analysis of 4 years shows Dianthus Therapeutics' Gross Profit stood at $1.2 million in 2022, then crashed by 63.74% to $426,000 in 2023, then soared by 211.27% to $1.3 million in 2024, then crashed by 81.77% to $396,000 in 2025.
- Its last three reported values are $396,000 in Q3 2025, $193,000 for Q2 2025, and $1.2 million during Q1 2025.